{
    "abstract": "Glioblastoma multiforme (GBM) is a glioma in IV stage, which is one of the most common primary malignant brain tumors in adults. GBM has the characters of high invasiveness, high recurrence rate, and low survival rate and with a poor prognosis. GBM implicates various genetic changes and epigenetic and gene transcription disorders, which are crucial in developing GBM. With the progression and enhancement of high-throughput sequencing technologies, the acquirement and administering approaches of diverse biological omics data on distinctive levels are developing more advanced. However, the research of GBM with multiomics remains largely unknown. We identified GBM-related molecular subtypes by integrated multiomics data and exploring the connections of gene copy number variation (CNV) and methylation gene (MET) change data. The expression of CNV and MET genes was examined through cluster integration analysis. The present study confirmed three clusters (iC1, iC2, and iC3) with distinctive prognosis and molecule peculiarities. We also recognized three oxidative stress protecting molecules (OSMR, IGFBP6, and MYBPH) by contrasting gene expression, MET, and CNV in the three subtypes. OSMR, IGFBP6, and MYBPH were differentially expressed in the clusters, suggesting they might be recognized as characteristic markers for the three clusters in GBM. Through integrative investigation of genomics, epigenomics, and transcriptomics, we offer novel visions into the multilayered molecules of GBM and facilitate the accuracy remedy for GBM sufferers.",
    "authors": [
        {
            "affiliation": "Department of Neurosurgery, Shengjing Hospital of China Medical University, Shenyang, Liaoning 11000, China.",
            "firstname": "Yawen",
            "initials": "Y",
            "lastname": "Ma"
        },
        {
            "affiliation": "Department of Neurosurgery, Shengjing Hospital of China Medical University, Shenyang, Liaoning 11000, China.",
            "firstname": "Zhuo",
            "initials": "Z",
            "lastname": "Xi"
        }
    ],
    "conclusions": null,
    "copyrights": "Copyright \u00a9 2022 Yawen Ma and Zhuo Xi.",
    "doi": "10.1155/2022/9993319\n10.3390/cancers13071678\n10.3390/biology10050390\n10.21037/tcr-21-74\n10.1016/j.ejphar.2021.173936\n10.1016/j.wneu.2022.03.089\n10.3892/mmr.2020.11160\n10.1016/j.tranon.2016.12.006\n10.1101/2021.07.25.453651\n10.1093/rheumatology/keab521\n10.1016/j.prp.2021.153525\n10.1093/neuonc/noac079.372\n10.1186/s12885-015-1796-6\n10.3390/ph14070618\n10.2991/assehr.k.210421.111\n10.14232/syrptbrs.2021.op38\n10.1016/S0049-3848(20)30405-9\n10.1101/2020.08.04.228536\n10.1158/1535-7163.MCT-14-0636\n10.1093/narcan/zcab045\n10.1016/j.neubiorev.2014.05.004\n10.2174/1389450121666200228112344\n10.3390/cancers12071796\n10.1016/j.canlet.2021.04.018\n10.1016/B978-012491543-5/50039-5\n10.1016/j.bbrc.2014.09.068\n10.1155/2021/2793222\n10.3389/fgene.2021.698163\n10.1007/s00439-016-1649-7\n10.1093/noajnl/vdac095\n10.18632/oncotarget.868\n10.1096/fba.2021-00016\n10.1111/jcmm.13738\n10.1016/j.fsi.2017.02.032\n10.3390/ijms21124428\n10.1016/j.prp.2020.152909\n10.3389/fcvm.2021.658915\n10.1016/j.phymed.2020.153372\n10.1172/JCI148667\n10.1186/s13058-021-01430-x\n10.1002/path.5063",
    "journal": "Oxidative medicine and cellular longevity",
    "keywords": [],
    "methods": null,
    "publication_date": "2022-10-05",
    "pubmed_id": "36193073\n33918235\n34062746\n35116473\n33581134\n35342027\n32467990\n28236760\n36185375\n34175943\n34171602\n26497383\n34198978\n32736787\n33932779\n26184483\n34870206\n24858130\n32107990\n32635549\n33933551\n25261722\n34326882\n34456973\n26969327\n35875691\n23548312\n34485840\n30117676\n28232194\n32580339\n32156471\n33959646\n33113505\n35192545\n34011405\n29473175",
    "results": null,
    "title": "Integrated Analysis of Multiomics Data Identified Molecular Subtypes and Oxidative Stress-Related Prognostic Biomarkers in Glioblastoma Multiforme.",
    "xml": "<Element 'PubmedArticle' at 0x788504ac8d60>"
}